Trimetamed
(Trimetazidine 35 g)
Cellular Energy Booster
Improves Angina Stability
No BP or Heart rate Impact
Trimetamed 35 contains Trimetazidine, a cytoprotective anti-anginal agent that improves heart muscle metabolism and energy efficiency without altering blood pressure or heart rate. It is prescribed for the long-term management of stable angina pectoris, especially in patients who cannot tolerate traditional hemodynamic agents like beta-blockers or calcium channel blockers. It enhances cardiac tolerance to ischemia, helping reduce chest pain and improve quality of life.
Uses:
- Management of chronic stable angina pectoris
- Adjunct to standard therapy in patients with ischemic heart disease
- Alternative for patients who cannot tolerate traditional anti-anginal drugs
Key Benefits:
- Reduces angina frequency and severity
- Improves cardiac energy metabolism in ischemic heart disease
- Maintains stable hemodynamic profile (no effect on BP or pulse)
- Can be safely combined with other cardiovascular medications
- Helps enhance exercise capacity and physical endurance
How It Works
- Trimetazidine acts at the cellular level by optimizing energy processes in the heart during oxygen deprivation (ischemia).
- It works by:
- Inhibiting fatty acid oxidation, thereby enhancing glucose oxidation
- This metabolic shift reduces intracellular acidosis, calcium overload, and free radical damage
- Preserves myocardial cell function and delays ischemic injury
Common Side Effects
- Nausea
- Vomiting
- Headache
- Abdominal discomfort
- Rash or itching (rare)
- Weakness or fatigue
Safety Warnings
- Pregnancy: Not recommended unless absolutely necessary and prescribed.
- Lactation: Avoid while breastfeeding.
- Children: Not intended for pediatric use.
- Elderly: Dose adjustment may be needed in patients with renal impairment.
Important Note
Trimetamed 35 should only be taken under the supervision of a qualified healthcare provider. It is not intended to treat acute angina attacks and should not replace emergency nitrates. Regular follow-up is essential to monitor for any neurologic or renal side effects. Do not self-medicate or share this medicine with others.